Cargando…
OR27-5 The De Novo Detection of Anti-Thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence
Background: The prevalence and clinical significance of de novo detection of anti-thyroglobulin antibodies (TgAb) during the follow up of patients with differentiated thyroid cancer (DTC), is unknown. Methods: We utilized the National Thyroid Cancer Treatment Cooperative Study registry (1987-2012)....
Autores principales: | Yin, Ngwe, Pak, Youngju, Sherman, Steven, Gianoukakis, Andrew, Group, NTCTCS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554831/ http://dx.doi.org/10.1210/js.2019-OR27-5 |
Ejemplares similares
-
MON-448 Detection of Thyroid Cancer Recurrence in Patients with Positive Thyroglobulin Antibody Receiving Immunoglobulin Therapy
por: Taiwo, Adeyinka, et al.
Publicado: (2020) -
Utility of Stimulated Thyroglobulin in the Differentiate Thyroid Cancer
por: Romero, Fabiola, et al.
Publicado: (2021) -
Can anti-thyroglobulin antibody (anti-Tg) be a tumor marker for recurrence in papillary thyroid carcinoma (PTC) in patients without autoimmune thyroiditis (AIT)?: A case report
por: Begüm Bahçecioğlu, Adile, et al.
Publicado: (2023) -
MON-458 Elevated Thyroglobulin Level in Benign Thyroid Nodule
por: Murphy, Cara, et al.
Publicado: (2020) -
LBODP104 Thyroid Plasmapheresis: An Alternative Option For Thyroid Storm
por: Khine, Aye, et al.
Publicado: (2022)